AVPT Stock Analysis: Avepoint | NASDAQ
Software - Infrastructure | NASDAQ, USA | Market Cap: 2.750m USD | 12M Return: -10.4% | US0536041041 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 21.5M
Qual. Beats: 1
Rev. Trend: 99.9%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 6.9 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
AvePoint, Inc. (NASDAQ: AVPT) is a U.S.-based cloud-native data management software provider, incorporated in 2001 and headquartered in Jersey City, New Jersey. The company operates across North America, Europe, the Middle East, Africa, and Asia Pacific, serving organizations that rely on third-party cloud platforms such as Microsoft, Salesforce, Google, AWS, Box, and Dropbox. Its platform-as-a-service (PaaS) architecture is organized into three suites: the Confidence Platforms Control Suite for SaaS data governance and policy enforcement; the Resilience Suite for business continuity, Backup-as-a-Service, and ransomware recovery; and the Modernization Suite for migrating legacy systems into AI-ready, SaaS-based environments. Revenue is generated through software licensing, support, and maintenance services.
AvePoint is classified within the Information Technology sector under the Application Software sub-industry (GICS), competing in the broader SaaS management and cloud data protection market. The company went public on July 2, 2021, and is positioned as a mid-cap provider focused on helping enterprises manage governance, compliance, and backup needs across multi-cloud SaaS environments.
- Microsoft 365 adoption fuels AvePoint data governance demand
- AI-ready modernization pipeline expands enterprise digital transformation bookings
- Veeam and native cloud competition pressures SaaS data management pricing
| Net Income: 71.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 1.90 > 1.0 |
| NWC/Revenue: 59.76% < 20% (prev 83.52%; Δ -23.76% < -1%) |
| CFO/TA 0.14 > 3% & CFO 104.7m > Net Income 71.5m |
| Net Debt (-400.9m) to EBITDA (71.7m): -5.59 < 3 |
| Current Ratio: 2.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (220.9m) vs 12m ago -3.63% < -2% |
| Gross Margin: 73.45% > 18% (prev 74.93%; Δ -1.49% > 0.5%) |
| Asset Turnover: 63.98% > 50% (prev 53.29%; Δ 10.70% > 0%) |
| Interest Coverage Ratio: 39.45 > 6 (EBIT TTM 58.8m / Interest Expense TTM 1.49m) |
| A: 0.37 (Total Current Assets 557.5m - Total Current Liabilities 278.9m) / Total Assets 757.0m |
| B: -0.70 (Retained Earnings -531.7m / Total Assets 757.0m) |
| C: 0.08 (EBIT TTM 58.8m / Avg Total Assets 728.6m) |
| D: 1.36 (Book Value of Equity 436.9m / Total Liabilities 320.1m) |
| Altman-Z'' = 2.10 = BBB |
| DSRI: 1.00 (Receivables 117.0m/93.3m, Revenue 466.2m/373.1m) |
| GMI: 1.02 (GM 74.93% / 73.45%) |
| AQI: 1.13 (AQ_t 0.22 / AQ_t-1 0.19) |
| SGI: 1.25 (Revenue 466.2m / 373.1m) |
| TATA: -0.04 (NI 71.5m - CFO 104.7m) / TA 757.0m) |
| Beneish M = -2.75 (Cap -4..+1) = A |
As of September 29, 2026, the stock is trading at USD 13.67 with a total of 2,682,870 shares traded. Over the past week, the price has changed by +2.32%, over one month by -2.36%, over three months by +23.49% and over the past year by -10.42%.
Current recommended Stop Loss: 13.10 (which is 4.2% or 1.3 ATR below the current price).
Avepoint has received a consensus analysts rating of 4.38. Therefore, it is recommended to buy AVPT.
- StrongBuy: 5
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 16.8 | 22.8% |
P/E Trailing = 41.9355
P/S = 5.9001
P/B = 6.3512
Revenue TTM = 466.2m USD
EBIT TTM = 58.8m USD
EBITDA TTM = 71.7m USD
Long Term Debt = unknown (none)
Short Term Debt = 7.50m USD (from shortTermDebt, last fiscal year)
Debt = 16.3m USD (from shortLongTermDebtTotal, last quarter) (leases 16.3m already included)
Net Debt = -400.9m USD (calculated: Debt 16.3m - CCE 417.2m)
Enterprise Value = 2.35b USD (2.75b + Debt 16.3m - CCE 417.2m)
Interest Coverage Ratio = 39.45 (Ebit TTM 58.8m / Interest Expense TTM 1.49m)
EV/FCF = 23.34x (Enterprise Value 2.35b / FCF TTM 100.7m)
FCF Yield = 4.28% (FCF TTM 100.7m / Enterprise Value 2.35b)
FCF Margin = 21.59% (FCF TTM 100.7m / Revenue TTM 466.2m)
Net Margin = 15.33% (Net Income TTM 71.5m / Revenue TTM 466.2m)
Gross Margin = 73.45% ((Revenue TTM 466.2m - Cost of Revenue TTM 123.8m) / Revenue TTM)
Gross Margin QoQ = 73.10% (prev 72.81%)
Tobins Q-Ratio = 3.10 (Enterprise Value 2.35b / Total Assets 757.0m)
Interest Expense / Debt = 9.14% (Interest Expense 1.49m / Debt 16.3m)
Taxrate = 13.29% (5.38m / 40.5m)
NOPAT = 51.0m (EBIT 58.8m * (1 - 13.29%))
Current Ratio = 2.00 (Total Current Assets 557.5m / Total Current Liabilities 278.9m)
Debt / Equity = 0.04 (Debt 16.3m / totalStockholderEquity, last quarter 436.9m)
Debt / EBITDA = -5.59 (Net Debt -400.9m / EBITDA 71.7m)
Debt / FCF = -3.98 (Net Debt -400.9m / FCF TTM 100.7m)
Total Stockholder Equity = 455.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.81% (Net Income 71.5m / Total Assets 757.0m)
RoE = 15.70% (Net Income TTM 71.5m / Total Stockholder Equity 455.3m)
RoCE = 12.30% (EBIT 58.8m / Capital Employed (Total Assets 757.0m - Current Liab 278.9m))
RoIC = 11.03% (NOPAT 51.0m / Invested Capital 462.3m)
WACC = 9.22% (E(2.75b)/V(2.77b) * Re(9.23%) + D(16.3m)/V(2.77b) * Rd(9.14%) * (1-Tc(0.13)))
Discount Rate = 9.23% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 83.19 | Cagr: 9.12%
[DCF] Terminal Value 75.20% ; FCFF base≈92.3m ; Y1≈105.8m ; Y5≈155.8m
[DCF] Fair Price = 11.50 (EV 2.03b - Net Debt -400.9m = Equity 2.43b / Shares 211.6m; r=9.22% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.93 | # QB: 1
Revenue Correlation: 99.87 | Revenue CAGR: 24.00% | SUE: 1.49 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.09 | Chg30d=+0.00% | Revisions=-79% | Analysts=12
EPS current Year (2026-12-31): EPS=0.45 | Chg30d=+0.00% | Revisions=+40% | GrowthEPS=+40.8% | GrowthRev=+21.7%
EPS next Year (2027-12-31): EPS=0.50 | Chg30d=+0.00% | Revisions=-15% | GrowthEPS=+10.4% | GrowthRev=+20.5%
[Analyst] Revisions Ratio: -19% (up=13, down=20)